Prestige Consumer Healthcare, Inc. (PBH)
46.57
-0.18
(-0.39%)
USD |
NYSE |
May 18, 16:00
46.57
0.00 (0.00%)
After-Hours: 16:50
Prestige Consumer Healthcare Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.51B |
| Amneal Pharmaceuticals, Inc. | 38.38M |
| Crinetics Pharmaceuticals, Inc. | 98.92M |
| Corcept Therapeutics, Inc. | 66.26M |
| Assertio Holdings, Inc. | 0.454M |